HBMK — Hubei Minkang Pharmaceutical Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Hubei Minkang Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2009 March 31st	2010 March 31st	2011 March 31st	2012 December 31st	2013 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.2	-1.83	-0.769	0.961	0.127
Depreciation
Amortisation
Non-Cash Items	0.081	1.76	0.702	—	—
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-0.04	0.123	-0.06	0.482	0.07
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	-0.158	0.047	-0.127	2.01	0.913
Capital Expenditures	-0.185	-0.09	0	-0.385	-0.205
Purchase of Fixed Assets
Other Investing Cash Flow Items	0	0	0	0.038	-0.534
Acquisition of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities	-0.185	-0.09	0	-0.347	-0.739
Financing Cash Flow Items	-0.476	0.047	0.089	-1.11	-0.18
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.338	0.047	0.121	1.28	-0.18
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.004	0.004	-0.006	2.97	0.161